SGK3 and polycystic ovary syndrome: Yao et al. demonstrated that SGK3 was targeted by miR-335-5p and SGK3 was increased in GCs from PCOS patients; furthermore, miR-335-5p suppressed GCs growth by targeting SGK3 [20].